Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

PerkinElmer to Host Revolutionaries for Global Health Summit

Published: Wednesday, May 01, 2013
Last Updated: Wednesday, May 01, 2013
Bookmark and Share
Company to assemble thought leaders to share pioneering personalized health research and innovations.

PerkinElmer Inc. is hosting a Revolutionaries for Global Health Summit from Wednesday May 8th through Thursday May 9th 2013 at the Boston Marriot Newton Hotel. The Summit is a forum for leading researchers and physicians to network and share best practices in both science and business and participate in cutting-edge discussions to help lead to better prevention, detection and treatment of disease. The meeting program will feature world-renowned experts presenting key insights on finding, understanding, and acting upon the causes and effects of disease including cancer, diabetes and heart disease.

“From Cradle to Grave, Health is Personal.”

"The Revolutionaries for Global Health Summit is a unique forum that fosters collaboration and shares research on how to use disruptive technologies to enable the advancement of human health. Recognized scientific leaders from biotech, pharma and academia will discuss their strategies and insights on how to enable better approaches for disease prevention, diagnosis and screening regimens, creating safer and more effective personalized therapeutics," said Kevin Hrusovsky, President, Life Sciences & Technology, PerkinElmer. “Once again, we look forward to bringing together hundreds of scientists from throughout leading research institutions around the world to the Boston area to share valuable insights and spark innovative discussions.”

The Summit will feature notable keynote presentations:
•    A presentation titled, “Quantitative Human Phenotyping: The Next Frontier,” will be given by Dennis A. Ausiello, MD, Physician-in-Chief at Massachusetts General Hospital.
•    Charles Mattocks, host of the TV Show “The Poor Chef”, will be sharing insights on a new movement called The Diabetic You, and how lifestyle and eating choices can complement modern medicine. In addition, he will be overseeing the preparation of all the food at the event to make sure that is not only delicious, but also healthy.
•    Dr. Richard Baum, Chairman and Clinical Director of THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, will present “Personalized Molecular Targeted Radiotherapy of Cancer.”
•    Kevin Hrusovsky will present, “From Cradle to Grave, Health is Personal.” In the past year, PerkinElmer has made tremendous progress in the fight against cancer and disease. This talk will focus on how technology has contributed to this progress.

Attendees will have the opportunity to participate in six informative tracks in the following areas: next generation sequencing, in vivo imaging, targeted small molecule discovery, proteins and biologics, tissue and cellular imaging/molecular pathology and enabling and accelerating science through laboratory services and informatics.

In support of PerkinElmer’s vision of preventing disease, the American Cancer Society will be at the summit sharing information and recruiting volunteers for their cancer prevention study.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PerkinElmer Sells NTD to Eurofins
PerkinElmer has announced that it sold its U. S. prenatal screening laboratory services business PerkinElmer Labs/NTD ("NTD") to Eurofins Scientific.
Tuesday, April 26, 2016
PerkinElmer Revenues Grow 4%
PerkinElmer, Inc. reported financial results for the fourth quarter ended December 29, 2013.
Monday, February 03, 2014
PerkinElmer Announces Collaboration with Rutgers University Cell and DNA Repository
Companies team up to enable large-scale sequencing studies through more efficient automation and improving next generation sequencing sample access.
Tuesday, February 21, 2012
Scientific News
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Magnetic Nanoparticles May Reveal Early Traces Of Cancer
Rice University students’ computer program aids MD Anderson diagnostic initiative .
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
World-First Blood Test For Parkinson's
La Trobe University researchers have developed a world-first diagnostic blood test which could change the lives of people with Parkinson's disease.
Parsortix Demonstrates Benefits Over Marker-Based Systems
Research published online in the International Journal of Cancer, shows the ParsortixTM System efficiently captures and harvests intact, viable circulating tumour cells (CTCs), including EpCAM-negative CTCs, to allow for broader downstream CTC analysis.
Hepatitis C Virus Testing Guidelines Miss Too Many Cases
Urban emergency departments a good place to enact universal screening for adults.
NIH Sequences Genome of a Fungus
Researchers at the Institute have sequenced genome of human, mouse and rat Pneumocystis that cause life-threatening Pneumonia in immunosuppressed hosts.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!